Suppr超能文献

临床研究表明,一种非处方的软固态止汗剂可以减少出汗量,并与男性志愿者使用的处方止汗剂产品进行了比较。

Clinical studies of sweat rate reduction by an over-the-counter soft-solid antiperspirant and comparison with a prescription antiperspirant product in male panelists.

机构信息

The Procter and Gamble Company, Beauty and Grooming - Gillette, Sharon Woods Technical Center, Cincinnati, OH, USA.

出版信息

Br J Dermatol. 2012 Mar;166 Suppl 1:22-6. doi: 10.1111/j.1365-2133.2011.10786.x.

Abstract

BACKGROUND

Individuals with axillary hyperhidrosis have much higher than average sweat rates and are often prescribed anhydrous aluminum chloride (AlCl(3)) solutions. Topical application of these solutions can be irritating to the skin, resulting in poor compliance and lower than desired efficacy.

OBJECTIVE

Demonstrate the efficacy of an over the counter "clinical strength" soft-solid antiperspirant using a night time application regimen and compare to a prescription aluminum chloride (6.5%) antiperspirant using male panelists.

METHODS

Gravimetric hot room efficacy testing (100 F and 35% Humidity) was performed comparing an over the counter soft-solid antiperspirant to placebo in a single test. Two separate gravimetric tests were placed comparing a prescription aluminum chloride (6.5%) antiperspirant to the same soft solid product using an intent to treat model. Skin irritation was assessed daily by a trained grader.

RESULTS

Placebo testing resulted in 85% of panelists having a reduction in sweating rate greater than 50%. Comparison testing showed the over the counter soft solid reduced sweat rate by an average of 34% better than the prescription product while resulting significantly less skin irritation.

CONCLUSIONS

Over the counter "clinical strength" soft-solid antiperspirants can be considered as an alternative treatment to aluminum chloride antiperspirants for the treatment of heavy sweating.

摘要

背景

患有腋窝多汗症的个体的出汗率远高于平均水平,通常会被开处方使用无水氯化铝(AlCl(3))溶液。这些溶液的局部应用可能会对皮肤产生刺激性,导致患者顺应性差且疗效低于预期。

目的

使用夜间应用方案展示一种非处方“临床强度”的软固态止汗剂的疗效,并与处方氯化铝(6.5%)止汗剂在男性志愿者中进行比较。

方法

在一项单次测试中,通过重量法热室功效测试(100°F 和 35%湿度),将一种非处方软固态止汗剂与安慰剂进行比较。通过意向治疗模型,进行了两项单独的重量法测试,将处方氯化铝(6.5%)止汗剂与同一软固态产品进行比较。由经过培训的评估员每天评估皮肤刺激情况。

结果

安慰剂测试显示,85%的志愿者的出汗率减少超过 50%。对比测试表明,非处方软固态产品比处方产品平均减少 34%的出汗率,同时皮肤刺激明显减少。

结论

非处方“临床强度”软固态止汗剂可以被视为替代氯化铝止汗剂治疗重度出汗的一种选择。

相似文献

2
Influence of climatic conditions on antiperspirant efficacy determined at different test areas.
Skin Res Technol. 2008 May;14(2):213-9. doi: 10.1111/j.1600-0846.2007.00282.x.
4
Thermoregulatory vs. event sweating--comparison of clinical methodologies, physiology and results.
Int J Cosmet Sci. 2014 Feb;36(1):102-8. doi: 10.1111/ics.12103. Epub 2013 Nov 27.
6
Efficient sweat reduction of three different antiperspirant application forms during stress-induced sweating.
Int J Cosmet Sci. 2013 Dec;35(6):622-31. doi: 10.1111/ics.12086. Epub 2013 Sep 2.
9
Histological localization of aluminum in topical aluminum chloride treatment for palmar hyperhidrosis.
J Dermatol Sci. 2012 Jul;67(1):69-71. doi: 10.1016/j.jdermsci.2012.02.016. Epub 2012 Mar 3.

引用本文的文献

1
Effects of Stimulus Temperature and Skin Hydration Levels on Wetness Perception at the Underarm.
Skin Res Technol. 2025 Feb-May;31(2-5):e70170. doi: 10.1111/srt.70170.
2
Primary Palmar Hyperhidrosis (PPH) Accompanied With Nevus Flammeus: A Case Report.
Cureus. 2023 May 8;15(5):e38723. doi: 10.7759/cureus.38723. eCollection 2023 May.
3
Treatment of Hyperhidrosis: An Update.
Am J Clin Dermatol. 2022 Sep;23(5):635-646. doi: 10.1007/s40257-022-00707-x. Epub 2022 Jul 1.
4
Secondary prevention of hidradenitis suppurativa.
Dermatol Reports. 2019 Oct 25;11(2):8243. doi: 10.4081/dr.2019.8243. eCollection 2019 Sep 19.
6
Gravimetry in sweating assessment in primary hyperhidrosis and healthy individuals.
Clin Auton Res. 2013 Aug;23(4):197-200. doi: 10.1007/s10286-013-0201-2. Epub 2013 Jun 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验